Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Depreciation & Amortization (CF) (2020 - 2024)

Historic Depreciation & Amortization (CF) for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $287000.0.

  • Therapeutics' Depreciation & Amortization (CF) fell 917.72% to $287000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.2 million, marking a year-over-year decrease of 123.36%. This contributed to the annual value of $1.2 million for FY2024, which is 106.91% down from last year.
  • Per Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $287000.0 for Q4 2024, which was down 917.72% from $300000.0 recorded in Q3 2024.
  • Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $400000.0 for Q2 2020, and its period low was $199000.0 during Q1 2020.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $300000.0 (2020), whereas its average is $274300.0.
  • Over the last 5 years, Therapeutics' Depreciation & Amortization (CF) had its largest YoY gain of 5075.38% in 2021, and its largest YoY loss of 5000.0% in 2021.
  • Over the past 5 years, Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $223000.0 in 2020, then fell by 10.31% to $200000.0 in 2021, then grew by 23.5% to $247000.0 in 2022, then rose by 27.94% to $316000.0 in 2023, then dropped by 9.18% to $287000.0 in 2024.
  • Its last three reported values are $287000.0 in Q4 2024, $300000.0 for Q3 2024, and $300000.0 during Q2 2024.